About Dr. Milano

A brief summary of Dr. Milano’s qualifications as an expert on medical risk appraisal and life expectancy rests on his over 2 decades years of training, experience and increasing responsibilities in life insurance medicine, a specialty in which he was board certified in 2001. Until retirement from full time corporate employment in 2004, Dr. Milano was an Associate Medical Director in the Medical Departments of several large indemnity institutions including:

• State Mutual Life Insurance Company of America (Allmerica) in Worcester, Massachusetts
   

• New England Life Insurance Company in Boston
   

• Metropolitan Life Insurance Company
   

• Medical Director and Research Medical Director at Business Men’s Assurance (now renamed Generali Reinsurance Life USA) in Kansas City, Missouri
   

• Dr. Milano currently is part-time Consulting Chief Medical Director of the Aviva Life Insurance Company in Quincy, Massachusetts

In the latter part of this career he devoted most of his time to research in mortality follow-up studies to improve company underwriting manuals for selection of risk in insurance applicants in such areas as coronary heart disease, cerebrovascular disease, cancer, diabetes mellitus, clinical depression, and evidence-based medicine.

Dr. Milano authored a number of articles on comparative mortality for the Journal of Insurance Medicine and other professional publications. For a number of years he conducted many training presentations, seminars, teaching practicums and consultations in North America to physicians, attorneys, life insurance underwriters and others on impairment-specific medical mortality, risk appraisal, life expectancy, large database analysis and automated electronic mortality and life expectancy methodologies.

A Medical Risk Appraisal and Life Expectancy Program has been developed by Dr. Milano useful in tort cases on behalf of medical malpractice defendants or plaintiffs, education of defense & plaintiff law practitioners, and physician and civil justice system advocacy that includes: software for the automated calculation of impairment-specific life expectancy.

He has also developed automated single and double decrement actuVerdana spreadsheet software methodologies for rapid and accurate conversion of tabular survival data to mortality and life expectancy for life, annuity, disability & structured settlement insurance products.

Since full-time corporate retirement Dr. Milano has continued this type of research and is currently engaged in cancer mortality research utilizing multiple demographic and clinical variables on more than 50 anatomic sites for 20-year prognostic follow up derived from the National Cancer Institute SEER (Surveillance, Epidemiology and End-Results study) database with planned publication of a 350-page clinical-actuVerdana monograph.

Dr. Milano currently serves on the Professional Liability Committee of the Massachusetts Medical Society where he has been licensed to practice medicine since 1968. He also serves on the Mortality and Morbidity Committee of the American Academy of Insurance Medicine and the Mortality and Morbidity Liaison Committee of the Society of Actuaries and the American Academy of Insurance Medicine. In addition, He has served intermittently as a medical expert for attorneys in cases involving a question of life expectancy since the year 2000.